معرفی
Helen Dakin is an Associate Professor at the University of Oxford, affiliated with the Health Economics Research Centre (HERC) and St Cross College. She specializes in health economics, with a focus on trial and model-based economic evaluations, uncertainty analysis, and factorial trial methodologies.
- Education: MSc in Economic Evaluation in Healthcare (City University), DPhil (University of Oxford), and BA/MSc in Biochemistry (Cambridge University)
Her research explores the cost-effectiveness of healthcare interventions across diverse fields, including clinical trials, diabetes management, orthopedic surgery, and ophthalmology. Key projects include the KAT trial (knee replacements), STAR trial (macular degeneration treatment), and SWEET trial (breast cancer adherence).
Recent publications highlight her work on maternal-fetal health outcomes, diabetes simulation models, orthopedic resource efficiency, and risk factor analysis for Type 2 Diabetes. She co-leads the Patient Reported Outcomes and Health Economics module of the MSc in Clinical Trials and directs HERC's online short course on integrating economic evaluation into clinical trials.
Helen actively contributes to advancing health economics methodologies and their application in real-world clinical trials, emphasizing practical implementation and policy impact.
